Form 4 for CELU Celularity Inc
Accepted 2022-08-30 00:00:00 ET · period of report 2022-08-26 · accession 0000899243-22-030099 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-08-30 | 2022-08-26 | CELU | SCULLEY JOHN | Dir | M - OptEx | $0.28 | +768.6K | 804.7K | +2,126% | +$215.2K |
| D | 2022-08-30 | 2022-08-26 | CELU | SCULLEY JOHN | Dir | M - OptEx | $0.00 | -768.6K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2022-08-26 | M | A | 768,594 | $0.28 | 804,739 | D | — | — | (F1) These shares include 36,145 restricted stock units ("RSUs") granted under the Celularity Inc. 2021 Equity Incentive Plan (the "2021 Plan"), with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs shall vest and become exercisable on the earlier of (i) July 13, 2023, such date being the one-year anniversary of the date of grant, and (ii) the next annual stockholder meeting; in each case subject to the Reporting Person's continuous service with the Issuer through such date |
| 2 | Derivative | Stock Option (Right to Buy) | 2022-08-26 | M | D | 768,594 | $0.00 | 0 | D | $0.28 · — to 2027-06-02 | 768,594 Class A Common Stock | (F2) This option is fully vested and exercisable. |